Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia
- 1 September 1989
- journal article
- Published by Elsevier in American Journal Of Medicine
- Vol. 87 (3), S27-S33
- https://doi.org/10.1016/0002-9343(89)80528-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Human Antithrombin Concentrates and Experimental Disseminated Intravascular CoagulationSeminars in Thrombosis and Hemostasis, 1985
- Anticoagulant therapy by continuous heparin-abtithrombin III infusion in newborns with disseminated intravascular coagulationEuropean Journal of Pediatrics, 1985
- Plasma Prekallikrein, Factor XII, Antithrombin III, C1−-Inhibitor and α2-Macroglobulin in Critically III Patients with Suspected Disseminated Intravascular Coagulation (DIC)American Journal of Clinical Pathology, 1984
- Antithrombin III concentrate as adjuvant in DIC treatment a pilot study in 9 severely ill patientsThrombosis Research, 1984
- Substitution therapy with an antithrombin III concentrate in shock and DICThrombosis Research, 1982
- Disseminated intravascular coagulation in hepatic failure treated with antithrombin IIIThrombosis Research, 1981
- The Relationship between Sepsis and Disseminated Intravascular CoagulationPublished by Wolters Kluwer Health ,1978
- Plasma Kallikrein and Hageman Factor in Gram-Negative BacteremiaAnnals of Internal Medicine, 1970
- Endotoxin ShockAnnals of Surgery, 1961
- Disseminated Intravascular CoagulationAnnals of Surgery, 1959